Erika R Vucko , APN
Nurse Practitioner β’ Chicago, IL
225 E Chicago Ave
Chicago, IL 606112991
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 8, 2015; this date does not establish years in practice.
-
Published CMS data list 60 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Sapropterin Dihydrochloride β 26 prescription fills, including refills.
- Javygtor (Sapropterin Dihydrochloride) β 22 prescription fills, including refills.
- Palynziq (Pegvaliase-Pqpz) β 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Chicago, IL (2024, 364 clinicians with data). Median for this group: 134. Middle half: 47 to 424.
Fewer Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Illinois (2024, 2,572 clinicians with data). Median for this group: 259. Middle half: 80 to 930.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 51 in 2020 to 60 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020β2024.
Practice Location & Contact Primary Location
225 E Chicago Ave
Chicago, IL 606112991
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Lurie Children'S Medical Group Inc.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Illinois College Of Med (Chi/peor/rock/chm-Urb)
2014
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
60 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$493,792 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $17,325.07 across 42 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $5,835.50 across 2 records.
- Consulting Fee: $5,332.09 across 5 records.
- Travel and Lodging: $4,046.47 across 9 records.
Reporting-company totals (3 largest of 9)
- BioMarin Pharmaceutical Inc.: $12,385.19 across 18 records.
- PTC Therapeutics, Inc.: $2,333.03 across 7 records.
- Amgen Inc.: $874.69 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
12 years (graduated 2014)
CMS Doctors and Clinicians data list 2014 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Erika Vucko has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Erika Vucko as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in Chicago, IL (2024, 364 clinicians with data). Median for this group: 134. Middle half: 47 to 424.
Fewer Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Illinois (2024, 2,572 clinicians with data). Median for this group: 259. Middle half: 80 to 930.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in Chicago, IL (2024, 364 clinicians with data). Median for this group: $7,605. Middle half: $492 to $57,977.
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Illinois (2024, 2,572 clinicians with data). Median for this group: $10,867. Middle half: $976 to $113,945.
952 active clinicians are listed under Nurse Practitioner with a practice address in Chicago, IL (4,894 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chicago
20% of these 952 clinicians have the CMS telehealth indicator.
56.2% of these 952 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 18% from 51 in 2020 to 60 in 2024.
- 2020: 51
- 2021: 24
- 2022: 36
- 2023: 30
- 2024: 60
-
30-day fills
30-day fills varied from year to year: 55 in 2020 and 60 in 2024.
- 2020: 55
- 2021: 34
- 2022: 38
- 2023: 30
- 2024: 60
-
Part D drug cost
Part D drug cost varied from year to year: $511,297 in 2020 and $493,792 in 2024.
- 2020: $511,297
- 2021: $477,318
- 2022: $184,723
- 2023: $246,631
- 2024: $493,792
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 177% from $6,260.54 in 2021 to $17,325.07 in 2025.
- 2021: $6,260.54
- 2022: $10,055.80
- 2023: $20,839.52
- 2024: $21,943.21
- 2025: $17,325.07
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 42 records totaling $17,325.07.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Palynziq | General | $3,000.00 |
| BioMarin Pharmaceutical Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Palynziq | General | $2,835.50 |
| BioMarin Pharmaceutical Inc. |
Consulting Fee
Cash or cash equivalent
|
Palynziq | General | $2,500.00 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $1,173.66 |
| PTC Therapeutics, Inc. |
Consulting Fee
Cash or cash equivalent
|
β | General | $975.00 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $883.12 |
| Amgen Inc. |
Consulting Fee
Cash or cash equivalent
|
RAVICTI | General | $844.59 |
| PTC Therapeutics, Inc. |
Consulting Fee
Cash or cash equivalent
|
β | General | $600.00 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $556.97 |
| PTC Therapeutics, Inc. |
Consulting Fee
Cash or cash equivalent
|
β | General | $412.50 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $343.50 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $315.38 |
| Chiesi USA, Inc. |
Honoraria
Cash or cash equivalent
|
MYALEPT | General | $300.00 |
| Chiesi USA, Inc. |
Honoraria
Cash or cash equivalent
|
ELFABRIO | General | $300.00 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. |
Travel and Lodging
In-kind items and services
|
β | General | $299.79 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. |
Travel and Lodging
In-kind items and services
|
β | General | $245.58 |
| PTC Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
SEPHIENCE | General | $195.67 |
| BioMarin Pharmaceutical Inc. |
Food and Beverage
In-kind items and services
|
Palynziq | General | $176.21 |
| BioMarin Pharmaceutical Inc. |
Food and Beverage
In-kind items and services
|
β | General | $123.75 |
| BioMarin Pharmaceutical Inc. |
Travel and Lodging
In-kind items and services
|
Palynziq | General | $119.37 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. |
Travel and Lodging
Cash or cash equivalent
|
β | General | $109.10 |
| BioMarin Pharmaceutical Inc. |
Food and Beverage
In-kind items and services
|
Palynziq | General | $103.38 |
| Cycle Pharmaceuticals Inc |
Food and Beverage
Cash or cash equivalent
|
Javygtor | General | $86.39 |
| Cycle Pharmaceuticals Inc |
Food and Beverage
Cash or cash equivalent
|
Nityr | General | $75.72 |
| PTC Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $73.42 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Sapropterin Dihydrochloride | Sapropterin Dihydrochloride | 26 | 780 | $113,092.41 | β |
| Javygtor | Sapropterin Dihydrochloride | 22 | 660 | $156,637.92 | β |
| Palynziq | Pegvaliase-Pqpz | 12 | 360 | $224,061.27 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-10-06NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20190226000013
IL
1951640622
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Lurie Children's Medical Group Inc.
225 E Chicago Ave, Chicago, IL 606112991
Phone: 3122276415
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Medical Genetics - Clinical Genetics (M.D.)
Doctor of Osteopathic Medicine (D.O.)
Audiologist
Doctor of Audiology
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 225 E CHICAGO AVE, CHICAGO, IL 606112991 (Tel: 3122276763)
NPI status registered as active in NPPES database
Registered at 155 E SUPERIOR ST, CHICAGO, IL 606112911 (Tel: 3122276763)
Registered at 225 E CHICAGO AVE, BOX 59, CHICAGO, IL 606112991 (Tel: 3122276763)
Recorded as ERIKA VUCKO, APN
Nurse Practitioner (license number reported to NPPES: IL 209012209)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Chicago
- Penny Viater
- Marlise Frey, CNP
- Kaitlyn Gill, FNP-C
- Christine Joy Locquiao, APRN, CNP
- Teri Dougherty, NP
- Kathleen Barak, APN
Mailing Address
225 E Chicago Ave, Box 59
Chicago, IL 606112991
Phone: 3122276763